DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,008 filers reported holding DANAHER CORPORATION in Q1 2022. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $143 | -99.9% | 22,200 | +72.1% | 0.02% | +7.1% |
| Q3 2022 | $216,000 | -33.5% | 12,900 | -32.1% | 0.01% | +55.6% |
| Q4 2021 | $325,000 | -44.3% | 19,000 | +0.5% | 0.01% | -52.6% |
| Q3 2021 | $584,000 | +86.0% | 18,900 | +148.7% | 0.02% | +90.0% |
| Q2 2021 | $314,000 | +2142.9% | 7,600 | -92.5% | 0.01% | +900.0% |
| Q4 2017 | $14,000 | -99.7% | 101,000 | -35.3% | 0.00% | -99.6% |
| Q3 2017 | $5,164,000 | +16558.1% | 156,099 | +1169.1% | 0.24% | +12150.0% |
| Q1 2017 | $31,000 | -99.4% | 12,300 | -93.8% | 0.00% | -99.2% |
| Q4 2016 | $4,971,000 | +4773.5% | 198,574 | +1181.1% | 0.25% | +6125.0% |
| Q3 2016 | $102,000 | -76.4% | 15,500 | -84.8% | 0.00% | -84.0% |
| Q2 2016 | $432,000 | -94.0% | 102,100 | -75.6% | 0.02% | -95.2% |
| Q1 2016 | $7,172,000 | -5.2% | 418,588 | -29.3% | 0.52% | +32.7% |
| Q3 2015 | $7,564,000 | +3401.9% | 592,002 | +46.5% | 0.39% | +2930.8% |
| Q2 2015 | $216,000 | -99.1% | 404,100 | -68.6% | 0.01% | -99.2% |
| Q1 2015 | $25,346,000 | -11.1% | 1,286,790 | +27.0% | 1.71% | +62.3% |
| Q4 2014 | $28,502,000 | +63237.8% | 1,013,345 | +6041.5% | 1.06% | +52650.0% |
| Q3 2014 | $45,000 | -51.1% | 16,500 | -44.1% | 0.00% | -33.3% |
| Q2 2014 | $92,000 | -89.7% | 29,500 | +148.4% | 0.00% | -92.5% |
| Q1 2014 | $891,000 | -85.9% | 11,876 | -98.9% | 0.04% | -79.6% |
| Q4 2013 | $6,315,000 | +223.8% | 1,039,800 | -0.1% | 0.20% | +216.1% |
| Q3 2013 | $1,950,000 | – | 1,041,200 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |